EP0574424A1
(de)
*
|
1991-03-04 |
1993-12-22 |
Warner-Lambert Company |
Salz/ionpaare von nicht-steroiden enzündungshemmenden arzneimitteln in verschiedenen dosierungsformen
|
JPH069382A
(ja)
*
|
1992-04-17 |
1994-01-18 |
Takeda Chem Ind Ltd |
安定化された固型製剤およびその製造方法
|
ZA933725B
(en)
*
|
1992-05-28 |
1993-12-15 |
Elan Corp Plc |
Tablet formulation
|
US5314697A
(en)
*
|
1992-10-23 |
1994-05-24 |
Schering Corporation |
Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
|
EP0674527A1
(de)
*
|
1992-12-21 |
1995-10-04 |
The Procter & Gamble Company |
Verwendung von s(+) antipoden von analgetika zur herstellung einer zusammensetzung zur behandlung von atemwegserkrankungen
|
DE69405752T2
(de)
*
|
1993-06-14 |
1998-02-05 |
Janssen Pharmaceutica Nv |
Filmbeschichtete tablette von astemizol und pseudoephedrin mit verlängerter freigabe
|
US6676967B1
(en)
*
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US20060263428A1
(en)
*
|
1993-09-20 |
2006-11-23 |
Eugenio Cefali |
Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US6129930A
(en)
|
1993-09-20 |
2000-10-10 |
Bova; David J. |
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
|
US6080428A
(en)
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US7211582B1
(en)
|
1994-12-30 |
2007-05-01 |
Sepracor Inc. |
Methods for treating urticaria using descarboethoxyloratadine
|
US7214683B1
(en)
|
1994-12-30 |
2007-05-08 |
Sepracor Inc. |
Compositions of descarboethoxyloratadine
|
EP0812195B1
(de)
*
|
1995-02-28 |
2002-10-30 |
Aventis Pharmaceuticals Inc. |
Arzneizubereitungen für piperidinalkanolderivate
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US6469009B1
(en)
*
|
1996-04-08 |
2002-10-22 |
Ucb, S.A. |
Pharmaceutical compositions for the treatment of rhinitis
|
ATE302599T1
(de)
*
|
1996-05-24 |
2005-09-15 |
Angiotech Pharm Inc |
Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
|
EP0811374A1
(de)
*
|
1996-05-29 |
1997-12-10 |
Pfizer Inc. |
Formulierung für ein Kombinationspräparat mit Cetirizin und Pseudoephedrin
|
TR199901003T2
(xx)
*
|
1996-10-31 |
1999-07-21 |
Schering Corporation |
Ast�m tedavisi i�in loratadin ve bir dekonjestan i�eren bile�im.
|
US6160020A
(en)
*
|
1996-12-20 |
2000-12-12 |
Mcneill-Ppc, Inc. |
Alkali metal and alkaline-earth metal salts of acetaminophen
|
TW522014B
(en)
*
|
1997-02-07 |
2003-03-01 |
Sepracor Inc |
Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
|
AU776837B2
(en)
*
|
1997-02-07 |
2004-09-23 |
Sunovion Pharmaceuticals Inc. |
Lactose-free non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
|
ES2318869T3
(es)
*
|
1997-02-20 |
2009-05-01 |
Massachusetts Institute Of Technology |
Forma de dosificacion que presenta propiedades de dispersion rapida, metodos de uso y procedimiento para su fabricacion.
|
BE1011045A3
(fr)
*
|
1997-03-14 |
1999-04-06 |
Ucb Sa |
Compositions pharmaceutiques pour la liberation controlee de substances actives.
|
US7179486B1
(en)
|
1997-04-01 |
2007-02-20 |
Nostrum Pharmaceuticals, Inc. |
Process for preparing sustained release tablets
|
US5895663A
(en)
*
|
1997-07-31 |
1999-04-20 |
L. Perrigo Company |
Pseudoephedrine hydrochloride extended-release tablets
|
KR100514264B1
(ko)
*
|
1997-08-26 |
2005-09-15 |
아벤티스 파마슈티칼스 인크. |
피페리디노알칸올-충혈완화제 조합용 제약 조성물
|
DE69916042T2
(de)
*
|
1998-07-10 |
2004-11-11 |
Schering Corp. |
Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-benzo[5,6]cyclohepta[1,2-b]pyridin
|
PA8481801A1
(es)
*
|
1998-09-10 |
2000-09-29 |
Schering Corp |
Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
|
US6521254B2
(en)
|
1998-12-07 |
2003-02-18 |
J-Med Pharmaceuticals, Inc. |
Single-dose antihistamine/decongestant formulations for treating rhinitis
|
KR100505899B1
(ko)
*
|
1999-02-23 |
2005-08-01 |
주식회사유한양행 |
로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
|
US6211246B1
(en)
|
1999-06-10 |
2001-04-03 |
Mcneil-Ppc, Inc. |
Rapidly absorbed liquid compositions
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6100274A
(en)
*
|
1999-07-07 |
2000-08-08 |
Schering Corporation |
8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
|
US6264983B1
(en)
*
|
1999-09-16 |
2001-07-24 |
Rhodia, Inc. |
Directly compressible, ultra fine acetaminophen compositions and process for producing same
|
US6267986B1
(en)
*
|
1999-09-24 |
2001-07-31 |
Ranbaxy Laboratories Limited |
Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
|
US6114346A
(en)
*
|
1999-10-22 |
2000-09-05 |
Schering Corporation |
Treating sleep disorders using desloratadine
|
AU2277101A
(en)
*
|
1999-12-20 |
2001-07-03 |
Schering Corporation |
Stable extended release oral dosage composition
|
SK287105B6
(sk)
|
1999-12-20 |
2009-12-07 |
Schering Corporation |
Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
|
US6613357B2
(en)
*
|
2000-01-13 |
2003-09-02 |
Osmotica Corp. |
Osmotic device containing pseudoephedrine and an H1 antagonist
|
DE10003757A1
(de)
*
|
2000-01-28 |
2001-08-02 |
Knoll Ag |
Ibuprofen-Wirkstoffzubereitung
|
US7405223B2
(en)
|
2000-02-03 |
2008-07-29 |
Schering Corporation |
Treating allergic and inflammatory conditions
|
JP5592042B2
(ja)
*
|
2000-04-14 |
2014-09-17 |
ジェイ−メド ファーマシューティカルズ,インコーポレーティッド |
鼻炎治療のための単一投与抗ヒスタミン薬/鬱血除去薬製剤
|
ES2185452B2
(es)
*
|
2000-08-01 |
2004-03-16 |
Cinfa S A Lab |
Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
|
US20020094345A1
(en)
|
2000-10-06 |
2002-07-18 |
Sara Abelaira |
Pharmaceutical compositions containing epinastine and pseudoephedrine
|
WO2002036077A2
(en)
*
|
2000-11-06 |
2002-05-10 |
Andrx Pharmaceuticals, Inc. |
Once a day antihistamine and decongestant formulation
|
US6982251B2
(en)
*
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
US7964216B2
(en)
|
2001-01-12 |
2011-06-21 |
Sun Pharma Advanced Research Company Limited |
Spaced drug delivery system
|
EP1785144A3
(de)
*
|
2001-01-26 |
2007-05-23 |
Shering Corporation |
Kombinationen von Gallensäurebinder(n) und Sterolabsorptionshemmer(n) und entsprechende Behandlung für vaskuläre Indikationen
|
ATE331512T1
(de)
*
|
2001-01-26 |
2006-07-15 |
Schering Corp |
Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie
|
EP1353694B1
(de)
*
|
2001-01-26 |
2007-12-19 |
Schering Corporation |
Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
|
US7071181B2
(en)
*
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
SI1385548T1
(sl)
*
|
2001-01-26 |
2007-10-31 |
Schering Corp |
Kombinacije zaviralca(-ev) absorpcije sterola s kardiovaskularnim(-i) sredstvom(-i) za zdravljenje vaskularnih obolenj
|
WO2002058685A2
(en)
*
|
2001-01-26 |
2002-08-01 |
Schering Corporation |
Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
|
US20060287254A1
(en)
*
|
2001-01-26 |
2006-12-21 |
Schering Corporation |
Use of substituted azetidinone compounds for the treatment of sitosterolemia
|
ATE374641T1
(de)
*
|
2001-01-26 |
2007-10-15 |
Schering Corp |
Kombinationen vom ppar-aktivator fenofibrat mit dem hemmer der sterol-absorption ezetimibe zur behandlung von kardiovaskulären indikationen
|
EP1377276B1
(de)
*
|
2001-04-10 |
2011-10-05 |
Sun Pharma Advanced Research Company Limited |
Zubereitung zur getakteten freisetzung
|
US20030013699A1
(en)
*
|
2001-05-25 |
2003-01-16 |
Davis Harry R. |
Methods for treating alzheimer's disease and/or regulating levels of amyloid beta peptides in a subject
|
CA2450583A1
(en)
*
|
2001-06-20 |
2003-01-03 |
Schering Corporation |
Antihistamines for the treatment of nasal congestion and nasal obstruction
|
BR0205721A
(pt)
*
|
2001-07-06 |
2003-09-30 |
Endo Pharmaceuticals Inc |
Formulações de oximorfona de liberação controlada
|
US6720002B2
(en)
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
US20030119808A1
(en)
*
|
2001-09-21 |
2003-06-26 |
Schering Corporation |
Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
|
US7056906B2
(en)
*
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
US7053080B2
(en)
*
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
SI1427409T1
(sl)
*
|
2001-09-21 |
2009-02-28 |
Schering Corp |
Postopki za zdravljenje ali preprečevanje vaskularnega vnetja z uporabo zaviralca(-ev) absorpcije sterola
|
ATE345793T1
(de)
*
|
2001-09-21 |
2006-12-15 |
Schering Corp |
Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
|
US7122143B2
(en)
|
2001-09-28 |
2006-10-17 |
Mcneil-Ppc, Inc. |
Methods for manufacturing dosage forms
|
US6837696B2
(en)
*
|
2001-09-28 |
2005-01-04 |
Mcneil-Ppc, Inc. |
Apparatus for manufacturing dosage forms
|
US7838026B2
(en)
|
2001-09-28 |
2010-11-23 |
Mcneil-Ppc, Inc. |
Burst-release polymer composition and dosage forms comprising the same
|
CN100408029C
(zh)
*
|
2001-09-28 |
2008-08-06 |
麦克内尔-Ppc股份有限公司 |
有镶嵌部分的组合剂型
|
AR040588A1
(es)
*
|
2002-07-26 |
2005-04-13 |
Schering Corp |
Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
|
US7560449B2
(en)
*
|
2002-11-06 |
2009-07-14 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of demyelination
|
US8092831B2
(en)
*
|
2002-11-08 |
2012-01-10 |
Andrx Pharmaceuticals, Llc |
Antihistamine and decongestant system
|
US7863287B2
(en)
*
|
2002-12-18 |
2011-01-04 |
Wyeth Llc |
Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
|
US20040253311A1
(en)
*
|
2002-12-18 |
2004-12-16 |
Roger Berlin |
Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
|
US20040142903A1
(en)
*
|
2003-01-16 |
2004-07-22 |
Par Pharmaceutical Inc. |
Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
|
ES2311806T3
(es)
*
|
2003-03-07 |
2009-02-16 |
Schering Corporation |
Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
|
JP2006519869A
(ja)
|
2003-03-07 |
2006-08-31 |
シェーリング コーポレイション |
置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
|
EP1601669B1
(de)
*
|
2003-03-07 |
2008-12-24 |
Schering Corporation |
Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
|
US7459442B2
(en)
*
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
DE602004018161D1
(de)
*
|
2003-07-28 |
2009-01-15 |
Mallinckrodt Inc |
Verbesserte stearat-zusammensetzung und herstellungsverfahren dafür
|
JP4919801B2
(ja)
*
|
2003-09-26 |
2012-04-18 |
アルザ・コーポレーシヨン |
高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法
|
JP2007510659A
(ja)
*
|
2003-11-05 |
2007-04-26 |
シェーリング コーポレイション |
脂質調節剤および置換アゼチジノンの組み合わせならびに血管状態の処置
|
US20050266032A1
(en)
*
|
2003-12-17 |
2005-12-01 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
US8188067B2
(en)
|
2004-04-01 |
2012-05-29 |
Teva Pharmaceutical Industries Ltd. |
Formulations of 6-mercaptopurine
|
US20070077297A1
(en)
|
2004-09-30 |
2007-04-05 |
Scolr Pharma, Inc. |
Modified release ibuprofen dosage form
|
US20060068009A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Scolr Pharma, Inc. |
Modified release ibuprofen dosage form
|
US20070036859A1
(en)
*
|
2005-08-11 |
2007-02-15 |
Perry Ronald L |
Sustained release antihistamine and decongestant composition
|
RU2008151945A
(ru)
*
|
2006-06-01 |
2010-07-20 |
Шеринг Корпорейшн (US) |
Лекарственные формы с пульсирующим высвобождением и фармацевтические композиции фенилэфрина
|
JP5175278B2
(ja)
|
2006-06-01 |
2013-04-03 |
エムエスディー コンシューマー ケア, インコーポレイテッド |
結腸吸収のためのフェニレフリン薬学的製剤および組成物
|
US7749537B2
(en)
*
|
2006-12-04 |
2010-07-06 |
Scolr Pharma, Inc. |
Method of forming a tablet
|
EP2240018B1
(de)
*
|
2008-01-04 |
2016-05-25 |
Schabar Research Associates LLC |
Zusammensetzung enthaltend ein analgetikum und ein antihistaminikum
|
US20130115250A1
(en)
*
|
2009-05-13 |
2013-05-09 |
Wyeth Llc |
Burst Drug Release Compositions
|
US20110104272A1
(en)
*
|
2009-11-05 |
2011-05-05 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine
|
CA2690490C
(en)
|
2010-01-19 |
2012-06-26 |
Accucaps Industries Limited |
Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
|
JP5752578B2
(ja)
*
|
2011-12-09 |
2015-07-22 |
ジェイ−メド ファーマシューティカルズ,インコーポレーティッド |
鼻炎治療のための単一投与抗ヒスタミン薬/鬱血除去薬製剤
|
EP2727592A1
(de)
*
|
2012-11-05 |
2014-05-07 |
Kücükgüzel, Sükriye Güniz |
Kombination aus Desloratadin und Paracetamol
|
PL3639828T3
(pl)
|
2013-12-24 |
2022-05-02 |
Virginia Commonwealth University |
Zastosowanie utlenowanych siarczanów cholesterolu (ocs) w leczeniu ostrej niewydolności wątroby
|
US20170105996A1
(en)
|
2015-10-16 |
2017-04-20 |
Teva Pharmaceutical Industries, Ltd. |
Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine
|
IL299845A
(en)
|
2020-07-15 |
2023-03-01 |
Schabar Res Associates Llc |
Oral unit dose compounds consisting of ibuprofen and famotidine for the treatment of acute pain and to reduce the severity and/or risk of heartburn
|
US11324727B2
(en)
|
2020-07-15 |
2022-05-10 |
Schabar Research Associates, Llc |
Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
|
EP4188339A1
(de)
|
2020-07-30 |
2023-06-07 |
Faes Farma, S.A. |
System zur abgabe eines dekongestiven arzneimittels
|